<p>Dosiomics in lung cancer</p>

Home - TD - Volume 4 - Issue 1

Journal Browser

Volume | Year

Issue

View All

Research Article

Dosiomics in lung cancer

Melek Yakar

^1*

1 Department of Radiation Oncology, Faculty of Medicine, Osmangazi University, Eskişehir

Tumor Discovery 2025, 4(1),129-131; https://doi.org/10.36922/td.8465

Submitted09 Jan 2025

Revised01 Jan 0001

Accepted14 Jan 2025

Published31 Jan 2025

Melek Yakar . (2025). <p>Dosiomics in lung cancer</p>. Tumor Discovery , 4(1), td8465. https://doi.org/10.36922/td.8465

REFERENCES

Dudas D, Dilling TJ, Naqa IE. A deep learning-informed interpretation of why and when dose metrics outside the PTV can affect the risk of distant metastasis in SBRT NSCLC patients. Radiat Oncol. 2024;19(1):127. doi: 10.1186/s13014-024-02519-1

Ma Z, Liang B, Wei R, et al. Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trial. Thorac Cancer. 2023;14(28):2839-2845. doi: 10.1111/1759-7714.15068

Zhou L, Wen Y, Zhang G, Wang L, Wu S, Zhang S. machine learning-based multiomics prediction model for radiation pneumonitis. J Oncol. 2023;2023:5328927. doi: 10.1155/2023/5328927

Adachi T, Nakamura M, Shintani T, et al. Multi-institutional dose-segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy. Med Phys. 2021;48(4):1781-1791. doi: 10.1002/mp.14769

Monti S, Xu T, Liao Z, Mohan R, Cella L, Palma G. On the interplay between dosiomics and genomics in radiation-induced lymphopenia of lung cancer patients. Radiother Oncol. 2022;167:219-225. doi: 10.1016/j.radonc.2021.12.038

Puttanawarut C, Sirirutbunkajorn N, Tawong N, et al. Radiomic and dosiomic features for the prediction of radiation pneumonitis across esophageal cancer and lung cancer. Front Oncol. 2022;12:768152. doi: 10.3389/fonc.2022.768152

Zhang Z, Wang Z, Yan M, et al. Radiomics and dosiomics signature from whole lung predicts radiation pneumonitis: A model development study with prospective external validation and decision-curve analysis. Int J Radiat Oncol Biol Phys. 2023;115(3):746-758. doi: 10.1016/j.ijrobp.2022.08.047

Bhandari A, Johnson K, Oh K, et al. Developing a novel dosiomics model to predict treatment failures following lung stereotactic body radiation therapy. Front Oncol. 2024;14:1438861. doi: 10.3389/fonc.2024.1438861

Previous：article in this issue

Next：article in this issue